Physicians' Academy for Cardiovascular Education

Colchicine reduces primary outcome in chronic coronary disease

3' education - Aug. 31, 2020 - Mark Nidorf, MD - Perth, Australia

Educational information

This video was recorded during the virtual congress of the ESC 2020.

Faculty

Mark Nidorf, MD - cardiologist, Perth, Australia

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the LoDoCo2 trial

Share this page with your colleagues and friends: